Skip to main content
. 2014 Jul 12;71(22):4325–4346. doi: 10.1007/s00018-014-1677-1

Table 3.

Ophthalmological findings

Assay Aging phenotype Intervention Strain, sex Treatment effects in aged mice Treatment effects in young mice References
Slit lamp examination with investigator-based rating of lens densities Increased mean cataract score Oral rapamycin (4.7, 14 or 42 ppm) initiated at 9 months of age Male and female UM-HET3 mice Cataract score further increased by treatment Not examined [18]
Scheimpflug imaging with computer-assisted automated measurements of lens densities Increased mean lens density Oral rapamycin (14 ppm) for approx. 1 year starting at 4 months or 13 months of age Male C57BL/6J Rj No effect Not examined [13]
Virtual drum vision test Reduced visual acuity Oral rapamycin (14 ppm) for approx. 1 year starting at 4 months or 13 months of age Male C57BL/6J Rj No effect Not examined [13]